SUMMARY The prevalence of cholesterol gall stones in young women has increased since the introduction of oral contraceptives. The synthetic female sex hormones used in these preparations, increase the degree of cholesterol saturation in bile. To determine whether oestrogens, progestagens, or 
Epidemiological studies'-"' have suggested that there must be a causal relationship between female sex hormones and gall-stone disease. Gall stones are twice as common in females once pubert y4 has been reached. After the menopause2-3 this sex difference gradually diminishes. Similarly, pregnancy3 and the use of synthetic female sex hormones for contraception>-9 or the prevention of postmenopausal symptoms"' have been shown to increase the incidence of gall-stone disease.
Approximately 85% of gall stones are composed predominantly of cholesterol. It is now recognised that cholesterol gall stones will form only when bile is supersaturated with cholesterol." Conversely, dissolution of cholesterol gall stones may occur when bile becomes unsaturated with cholesterol. [12] [13] [14] In 1973 Thomas and Hofmann'5 introduced the cholesterol saturation index (CSI) to quantify the degree of cholesterol saturation in bile. Any substance or factor that increases the cholesterol saturation index of bile may alter the relative time periods of cholesterol unsaturation to supersaturation during the day in favour of cholesterol supersaturation within the gall bladder and lead to cholesterol crystal formation and gallstone growth. '6 Studies' [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] New York, USA). Gall-bladder bile samples were aspirated from the duodenum after a slow intravenous injection of 1 U/kg Pancreozymin (Boots Co Ltd, Nottingham, England). A 2 ml sample of the most concentrated bile was immediately sent to the laboratory for lipid analysis. Excess bile was returned to the duodenum to avoid depletion of the bile acid pool.
BILE LIPID ANALYSIS
The biliary lipids (cholesterol, total bile acids, and phospholipids) were assayed using fresh bile for solvent extraction as described by Whiting et al. '8 Assays were performed in several batches as samples became available during the study. The cholesterol saturation index was calculated by the method of Thomas and Hofmann'5 using the cholesterol equilibrium saturation limit of Holzbach et al.32
Individual bile acids in the gall-bladder bile samples were deconjugated and quantified by gas liquid chromatography as described by Whiting and Watts.33 Individual bile acid profiles were determined by expressing the relative concentrations of the individual bile acids as moles per cent.
BILE ACID POOL SIZE
The total bile acid pool size was measured by the simplified isotope dilution technique of Duane et al. 3 Two minor modifications were used. Firstly, the 10 ml intravenous injection of radioactive cholate was always given half an hour before eating the standard evening meal. Secondly, the addition of non-radioactive sodium cholate to the vial of radioactive cholic acid proved essential to prevent major losses from the solution of radioactive cholate by absorption to glass surfaces. 14C-carboxyl cholic acid (specific activity 50-60 mCi/mol; the Radio Chemical Centre, Amersham, England) and (2,4- 3H) cholic acid (specific activity 14 Ten millilitres of blood were obtained by venepuncture with each bile sample. The serum was separated and snap frozen at -70(C for subsequent batch hormone analysis. The serum progesterone was determined by radioimmunoassay after hexane extraction.
STATISTICS
A precise measure of the cholesterol saturation of duodenal bile requires multiple samples. 18 35 Therefore, the average of the two or three cholesterol saturation index measurements in each phase of the study was used for statistical analysis. The Wilcoxon's signed rank test for paired samples was used to analyse all data.
Results
Seven of the subjects completed all phases of the study, while the other three were able to participate only in a control phase and two oestrogen/ progestagen phases because they left the area. The control menstrual cycles proved to be ovular in all subjects by measurement of serum progesterone levels. The oestrogen/progestagen combinations induced an anovular cycle in all subjects except one. This subject ovulated while taking 30 ,ug ethinyloestradiol alone. The daily dose of synthetic female sex hormone(s) in each phase was tolerated well by all women except one who developed early morning nausea and vomiting while taking 30 ,ug ethinyloestradiol plus 150 ,g norgestrel. None of the women had major changes in their weight during the year of study. The daily ingestion of 30 ,ug ethinyloestradiol alone in this study had no significant effect on the degree of cholesterol saturation in bile even though the cycles were anovular. This suggests that the increase in the biliary cholesterol saturation index which was observed with ethinyloestradiol plus norgestrel cannot be attributed to ethinyloestradiol, nor the suppression of physiological oestrogens, progesterone, luteinising hormone, or follicular stimulating hormone. Only one other study on the effect of 30 Mug ethinyloestradiol has been carried out, and it was performed in men, not women.37 It showed that this dose of ethinyloestradiol resulted in a significant rise in the bile cholesterol saturation index after seven days' treatment. The reason for this sex difference is unclear, but it may be related to the 50% fall in the levels of circulating testosterone which also accompanied the use of ethinyloestradiol in men.:
The importance of the increase in the biliary cholesterol saturation index which was observed with the combined oral contraceptives containing 30 progestagen potency ratio of an oral contraceptive may, therefore, be more important in determining its effects on the biliary cholesterol saturation index than the dose of each sex hormone. This theory already has some support as an inverse correlation has been shown between the oestrogen to progestagen ratio of oral contraceptives and the risk of developing gall stones.6 Future studies into the effect of sex hormones on bile should consider not only the doses of oestrogen and progestagen, but also the overall oestrogen to progestagen potency ratio.
None of the oestrogen/progestagen combinations used in our study significantly changed the total bile acid pool size or the bile acid profile of bile, except for ethinyloestradiol alone, which decreased the proportion of chenodeoxycholic acid. Other studies'9 22 23 have also found that both endogenous and exogenous female sex hormones are associated with a decreased proportion of chenodeoxycholic acid in bile. It is not clear, however, whether this change is related to an increase in the cholesterol saturation index of bile. Our results also show that increases in the biliary cholesterol saturation index can occur with combination oral contraceptives without concomitant changes in bile acid composition, and support the more recent study of Bennion et al.4 ) They were unable to show a change in total bile acid pool size or bile acid composition with oral contraceptives, even though the biliary cholesterol saturation index increased. Instead, they showed that the increase in the biliary cholesterol saturation index was because of hepatic enhancement of cholesterol secretion into bile.
In conclusion, our study has shown that the progestagen, norgestrel, and not the oestrogen, ethinyloestradiol, is responsible for the increase in bile cholesterol saturation which accompanies the use of oral contraceptives. 225 It also suggests that this side effect is not a property of all progestagens.
If future studies confirm these findings, it may be possible to manufacture oral contraceptives which do not subject women to an increased risk of gall-stone formation. 
